Joshua Aiello - 12 Feb 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Reporting relationship: Principal Accounting Officer
Issuer ticker: OBIO
Reported as of: 12 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Feb 2026, 17:02:11 UTC
Prior SEC filing: 02 Jan 2026
Next SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Taylor, Attorney-in-Fact

Key filing fact

Joshua Aiello filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 13 Feb 2026.

Key facts

This page summarizes Joshua Aiello's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Feb 2026, 17:02.

Change

Previous filing in this sequence was filed on 02 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001960418 Primary reporting owner

Aiello Joshua

Relationship: Principal Accounting Officer
Address: C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Signature date: 13 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OBIO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +70,000
Change %
Price: $0.000000
Shares after: 70,000
Date: 12 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 70,000
Exercise price: $3.82
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options will vest as follows: (i) 25% of the stock options will vest on February 12, 2027 (the "Vesting Commencement Date") and (ii) the remaining 75% stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on May 12, 2027, subject to the Reporting Person's continuous service through such dates.